Literature DB >> 16252245

Children with idiopathic hemihypertrophy and beckwith-wiedemann syndrome have different constitutional epigenotypes associated with wilms tumor.

Emily L Niemitz1, Andrew P Feinberg, Sheri A Brandenburg, Paul E Grundy, Michael R DeBaun.   

Abstract

Idiopathic hemihypertrophy (IH) is a congenital overgrowth syndrome associated with an increased risk of embryonal cancers in childhood. A related developmental disorder is Beckwith-Wiedemann syndrome (BWS), which increases risk for embryonal cancers, including Wilms tumor. Constitutional epigenetic alterations associated with BWS have been well characterized and include epigenetic alterations of imprinted genes on 11p15. The frequency of hypermethylation of H19 in children with IH and Wilms tumor, 20% (3/15), was significantly lower than the frequency in children with BWS and Wilms tumor, 79% (11/14; P = .0028). These results indicate that children with IH and Wilms tumor have different constitutional epigenotypes from those of children with BWS and Wilms tumor.

Entities:  

Mesh:

Year:  2005        PMID: 16252245      PMCID: PMC1271394          DOI: 10.1086/497540

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  10 in total

Review 1.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

2.  Chromosome 11 uniparental isodisomy predisposing to embryonal neoplasms.

Authors:  P Grundy; P Telzerow; M C Paterson; D Haber; B Berman; F Li; J Garber
Journal:  Lancet       Date:  1991-10-26       Impact factor: 79.321

3.  Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects.

Authors:  Michael R DeBaun; Emily L Niemitz; D Elizabeth McNeil; Sheri A Brandenburg; Maxwell P Lee; Andrew P Feinberg
Journal:  Am J Hum Genet       Date:  2002-01-28       Impact factor: 11.025

4.  Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.

Authors:  J D Ravenel; K W Broman; E J Perlman; E L Niemitz; T M Jayawardena; D W Bell; D A Haber; H Uejima; A P Feinberg
Journal:  J Natl Cancer Inst       Date:  2001-11-21       Impact factor: 13.506

5.  16q loss of heterozygosity and microsatellite instability in Wilms' tumor.

Authors:  J E Mason; P J Goodfellow; P E Grundy; M A Skinner
Journal:  J Pediatr Surg       Date:  2000-06       Impact factor: 2.545

6.  Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry.

Authors:  M R DeBaun; M A Tucker
Journal:  J Pediatr       Date:  1998-03       Impact factor: 4.406

7.  Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability.

Authors:  H Cui; I L Horon; R Ohlsson; S R Hamilton; A P Feinberg
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

Review 8.  Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review.

Authors:  H E Hoyme; L H Seaver; K L Jones; F Procopio; W Crooks; M Feingold
Journal:  Am J Med Genet       Date:  1998-10-02

9.  Age distribution of Wilms' tumor: report from the National Wilms' Tumor Study.

Authors:  N Breslow; J B Beckwith; M Ciol; K Sharples
Journal:  Cancer Res       Date:  1988-03-15       Impact factor: 12.701

10.  A nearly continuous measure of birth weight for gestational age using a United States national reference.

Authors:  Emily Oken; Ken P Kleinman; Janet Rich-Edwards; Matthew W Gillman
Journal:  BMC Pediatr       Date:  2003-07-08       Impact factor: 2.125

  10 in total
  8 in total

1.  Expanding the phenotype of mutations in DICER1: mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome.

Authors:  Steven Klein; Hane Lee; Shahnaz Ghahremani; Pamela Kempert; Mariam Ischander; Michael A Teitell; Stanley F Nelson; Julian A Martinez-Agosto
Journal:  J Med Genet       Date:  2014-03-27       Impact factor: 6.318

2.  Reply to Brioude et al.

Authors:  Jack Brzezinski; Cheryl Shuman; Sanaa Choufani; Peter Ray; Dimitri J Stavropoulos; Raveen Basran; Leslie Steele; Nicole Parkinson; Ronald Grant; Paul Thorner; Armando Lorenzo; Rosanna Weksberg
Journal:  Eur J Hum Genet       Date:  2018-02-15       Impact factor: 4.246

3.  Wilms tumour in Beckwith-Wiedemann Syndrome and loss of methylation at imprinting centre 2: revisiting tumour surveillance guidelines.

Authors:  Jack Brzezinski; Cheryl Shuman; Sanaa Choufani; Peter Ray; Dmitiri J Stavropoulos; Raveen Basran; Leslie Steele; Nicole Parkinson; Ronald Grant; Paul Thorner; Armando Lorenzo; Rosanna Weksberg
Journal:  Eur J Hum Genet       Date:  2017-07-12       Impact factor: 4.246

Review 4.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors:  R H Scott; C A Stiller; L Walker; N Rahman
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

5.  Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor.

Authors:  Norman E Breslow; J Bruce Beckwith; Elizabeth J Perlman; Anthony E Reeve
Journal:  Pediatr Blood Cancer       Date:  2006-09       Impact factor: 3.167

6.  Hemifacial hypertrophy: Exploring new avenues of treatment modalities.

Authors:  Santosh Ashok Nandimath; G C Rajkumar; Tulasi Nayak; D P Ashwin; K B Rudresh; R Prashanth
Journal:  Natl J Maxillofac Surg       Date:  2016 Jan-Jun

Review 7.  Many faces of Wilms Tumor: Recent advances and future directions.

Authors:  Namita Bhutani; Pradeep Kajal; Urvashi Sharma
Journal:  Ann Med Surg (Lond)       Date:  2021-03-07

8.  Diagnostic criteria and tumor screening for individuals with isolated hemihyperplasia.

Authors:  Carol L Clericuzio; Rick A Martin
Journal:  Genet Med       Date:  2009-03       Impact factor: 8.822

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.